PCP
NBIX icon

Proficio Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Proficio Capital Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-106
Closed -$9K – 1019
2019
Q2 		$9K Buy
106
+39
+58% +$3.2K ﹤0.01% 977
2019
Q1 		$6K Buy
67
+6
+10% +$501 ﹤0.01% 1061
2018
Q4 		$4K Hold
61
– – ﹤0.01% 904
2018
Q3 		$7K Hold
61
– – ﹤0.01% 890
2018
Q2 		$6K Hold
61
– – ﹤0.01% 954
2018
Q1 		$5K Hold
61
– – ﹤0.01% 1006
2017
Q4 		$5K Buy
61
+5
+9% +$341 ﹤0.01% 977
2017
Q3 		$3K Hold
56
– – ﹤0.01% 1036
2017
Q2 		$3K Hold
56
– – ﹤0.01% 1050
2017
Q1 		$3K Buy
+56
New +$2.4K ﹤0.01% 1082
2016
Q4 		– Sell
-11
Closed -$1K – 1164
2016
Q3 		$1K Buy
+11
New +$548 ﹤0.01% 993

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return